FSD Pharma Inc Stock
FSD Pharma Inc Stock price
Key metrics
| Market capitalization | $42.10m |
| Enterprise Value | $39.84m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 7.27 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-17.28m |
| Free Cash Flow (TTM) Free Cash Flow | $-9.16m |
| Cash position | $3.54m |
Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
FSD Pharma Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast FSD Pharma Inc:
Analyst Opinions
1 Analyst has issued a forecast FSD Pharma Inc:
Financial data from FSD Pharma Inc
| Mar '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -17 -17 |
58%
58%
|
EBIT (Operating Income) EBIT | -17 -17 |
42%
42%
|
| Net Profit | -21 -21 |
100%
100%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
FSD Pharma Inc Stock News
Company Profile
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.
| Head office | Canada |
| CEO | Zeeshan Saeed |
| Founded | 1994 |
| Website | www.fsdpharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
